These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 20567103

  • 1. [Immunohistochemical and clinicopathological study of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyl transferase expression in oral cancer patients responding to UFT].
    Kawasaki G, Yoshitomi I, Yanamoto S, Yamada S, Kawano T, Mizuno A.
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):1035-9. PubMed ID: 20567103
    [Abstract] [Full Text] [Related]

  • 2. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
    Ishida H, Yamada H, Shirakawa K, Nakada H, Ohsawa T, Takeuchi I, Okada N, Yokoyama M, Inokuma S, Suzuki T, Odaka A, Hoshino T, Murata N, Hashimoto D, Itoyama S, Mori T, Matsumoto Y, Miura T.
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1621-6. PubMed ID: 14619479
    [Abstract] [Full Text] [Related]

  • 3. [Correlation between clinical pathologic factors and enzymatic activity of orotate Phosphoribosyl transferase (OPRT), Dihydropyrimidine dehydrogenase (DPD) and Thymidylate synthase (TS) in colorectal cancer].
    Yamada T, Tanaka N, Yokoi K, Ishikawa N, Seya T, Kanazawa Y, Shirakawa T, Ohkawa K, Koizumi M, Ohaki Y, Yamashita K, Tajiri T.
    Gan To Kagaku Ryoho; 2006 Jun; 33(6):789-93. PubMed ID: 16770098
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
    Miyoshi T, Kondo K, Toba H, Yoshida M, Fujino H, Kenzaki K, Sakiyama S, Takehisa M, Tangoku A.
    Anticancer Res; 2007 Jun; 27(4C):2641-8. PubMed ID: 17695427
    [Abstract] [Full Text] [Related]

  • 5. Clinical role of orotate phosphoribosyl transferase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
    Tokunaga Y, Sasaki H, Saito T.
    Surgery; 2007 Mar; 141(3):346-53. PubMed ID: 17349846
    [Abstract] [Full Text] [Related]

  • 6. [Expression of mRNA levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase of colorectal cancer--relationships among mRNA levels in association with response to 5-FU based treatment].
    Ishida H, Shirakawa K, Ohsawa T, Sobajima J, Hayashi Y, Nakada H, Yokoyama M, Hashimoto D.
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1929-34. PubMed ID: 16282729
    [Abstract] [Full Text] [Related]

  • 7. Correlations of clinicopathological factors with protein expression levels of thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in colorectal cancer.
    Sumi T, Katsumata K, Tsuchida A, Ishizaki T, Shimazu M, Aoki T.
    Chemotherapy; 2010 Nov; 56(2):120-6. PubMed ID: 20407238
    [Abstract] [Full Text] [Related]

  • 8. Quantitative double-fluorescence immunohistochemistry (qDFIHC), a novel technology to assess protein expression: a pilot study analyzing 5-FU sensitive markers thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferases in gastric cancer tissue specimens.
    Kai K, Kitajima Y, Hiraki M, Satoh S, Tanaka M, Nakafusa Y, Tokunaga O, Miyazaki K.
    Cancer Lett; 2007 Dec 08; 258(1):45-54. PubMed ID: 17892912
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K, Ferdous T, Itashiki Y, Takii M, Mano T, Mori Y, Ueyama Y.
    Anticancer Res; 2009 Apr 08; 29(4):1263-70. PubMed ID: 19414373
    [Abstract] [Full Text] [Related]

  • 11. Expression of thymidylate synthase, orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in thymic epithelial tumors.
    Kaira K, Serizawa M, Koh Y, Miura S, Kaira R, Abe M, Nakagawa K, Ohde Y, Okumura T, Murakami H, Tsuya A, Nakamura Y, Naito T, Takahashi T, Kondo H, Nakajima T, Endo M, Yamamoto N.
    Lung Cancer; 2011 Dec 08; 74(3):419-25. PubMed ID: 21550686
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and toxicity of S-1 plus cisplatin combination neoadjuvant chemotherapy in patients with oral cancer.
    Kawasaki G, Yoshitomi I, Yanamoto S, Yamada S, Mizuno A.
    Gan To Kagaku Ryoho; 2011 Jun 08; 38(6):951-7. PubMed ID: 21677485
    [Abstract] [Full Text] [Related]

  • 13. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
    Fukui Y, Oka T, Nagayama S, Danenberg PV, Danenberg KD, Fukushima M.
    Int J Mol Med; 2008 Dec 08; 22(6):709-16. PubMed ID: 19020767
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H, Iinuma H, Watanabe T.
    Oncol Rep; 2008 Mar 08; 19(3):729-35. PubMed ID: 18288408
    [Abstract] [Full Text] [Related]

  • 15. Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: an immunohistochemical and clinicopathologic study.
    Kawasaki G, Yoshitomi I, Yanamoto S, Mizuno A.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Dec 08; 94(6):717-23. PubMed ID: 12464897
    [Abstract] [Full Text] [Related]

  • 16. [Correlation between clinical pathophysiologic factors and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer].
    Ochiai T, Sugitani M, Nishimura K, Noguchi H, Watanabe T, Sengoku H, Komiyama H, Okano M.
    Gan To Kagaku Ryoho; 2002 Mar 08; 29(3):413-20. PubMed ID: 11915731
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancer.
    Kamoshida S, Shiogama K, Shimomura R, Inada K, Sakurai Y, Ochiai M, Matuoka H, Maeda K, Tsutsumi Y.
    Oncol Rep; 2005 Nov 08; 14(5):1223-30. PubMed ID: 16211289
    [Abstract] [Full Text] [Related]

  • 18. Expression of dihydropyrimidine dehydrogenase, orotate phosphoribosyl transferase and thymidylate synthase in patients with primary colorectal cancer, and associations with site of first metastasis.
    Akagi Y, Kinugasa T, Mizobe T, Kawahara A, Kage M, Shirouzu K.
    Anticancer Res; 2012 Jun 08; 32(6):2277-82. PubMed ID: 22641663
    [Abstract] [Full Text] [Related]

  • 19. Thymidylate synthase and dihydropyrimidine dehydrogenase expression levels are associated with response to S-1 plus carboplatin in advanced non-small cell lung cancer.
    Takeda M, Okamoto I, Hirabayashi N, Kitano M, Nakagawa K.
    Lung Cancer; 2011 Jul 08; 73(1):103-9. PubMed ID: 21111509
    [Abstract] [Full Text] [Related]

  • 20. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
    Yamada T, Tanaka N, Yokoi K, Ishikawa N, Seya T, Horiba K, Kanazawa Y, Shirakawa T, Ohkawa K, Kudoh H, Koizumi M, Yoshioka M, Shinji S, Yamashita K, Tajiri T.
    Gan To Kagaku Ryoho; 2006 Nov 08; 33(11):1603-9. PubMed ID: 17108726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.